In a previous study, the upregulation of OPA1 promoted tumor angiogenesis by suppressing NF-κB activation [16], while in this study, celastrol administration decreased OPA1, followed by p-P65 upregulation, which is the signal of NF-κB activation, thus showing the anti-angiogenesis effect. The gene discussed is NFKB1; the disease is neoplasm.